mRNA vaccine
| 4 min read
New vaccines and antiviral injections that could offer significantly better and broader protection against the flu are now in clinical trials.
| 2 min read
The state-of-the-art facility will deliver CGMP plasmid DNA development and manufacturing services by late 2025.
| 4 min read
Cancer researchers in biotech and pharma highlight the clinical trials and developments they’re most excited about.
| 4 min read
Scientists probed how tick proteins influenced host immunity, paving the way for mRNA vaccines to block Lyme and other tick-borne diseases.
| 5 min read
From advances in graft versus host disease treatment to updates on H5N1 and Duchenne muscular dystrophy research, the DDN editors break down the news this week.
| 5 min read
Katalin Karikó and Drew Weissman received this year’s Physiology or Medicine award for their work on RNA biology and mRNA-based vaccines.
Available on Demand
Automated synthetic biology workflows enable efficient mRNA-based therapeutic development.
| 8 min read
After tragedy struck during a 1960s clinical trial, development of a vaccine for RSV ground to a halt. But as new RSV vaccine candidates enter late-stage clinical trials, a safe and effective vaccine is finally in sight.
Page 1 of 1 - 8 Total Items
